$WDDD
Worlds Inc

2024 Q4 Form 10-Q Financial Statement

#000126493124000052 Filed on November 12, 2024

View on sec.gov

Income Statement

Concept 2024 Q4 2024 Q3 2023 Q3
Revenue
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $61.97K $16.26K
YoY Change 281.06% -65.61%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $61.97K $16.26K
YoY Change 281.06% -65.61%
Operating Profit -$127.1K -$70.09K
YoY Change 81.34% -30.21%
Interest Expense $19.13K $20.63K
YoY Change -7.29% 7.87%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income -$90.00K
YoY Change -537.32%
Income Tax
% Of Pretax Income
Net Earnings -$146.2K -$90.72K
YoY Change 61.18% -540.82%
Net Earnings / Revenue
Basic Earnings Per Share $0.00 $0.00
Diluted Earnings Per Share $0.00
COMMON SHARES
Basic Shares Outstanding 57.11M shares 57.11M shares 57.11M shares
Diluted Shares Outstanding 57.11M shares

Balance Sheet

Concept 2024 Q4 2024 Q3 2023 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $30.00K
YoY Change -48.28%
Cash & Equivalents $31.25K $31.09K
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses $20.55K
Receivables
Other Receivables
Total Short-Term Assets $51.80K $31.09K
YoY Change 66.62% -53.05%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $0.00 $0.00
YoY Change -100.0%
TOTAL ASSETS
Total Short-Term Assets $51.80K $31.09K
Total Long-Term Assets $0.00 $0.00
Total Assets $51.80K $31.09K
YoY Change 66.62% -89.92%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $798.9K $797.9K
YoY Change 0.13% -1.14%
Accrued Expenses $1.747M $1.870M
YoY Change -6.58% 19.53%
Deferred Revenue
YoY Change
Short-Term Debt $800.0K
YoY Change 3.46%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $3.568M $3.471M
YoY Change 2.78% 10.38%
LONG-TERM LIABILITIES
Long-Term Debt $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $3.568M $3.471M
Total Long-Term Liabilities $0.00
Total Liabilities $3.568M $3.471M
YoY Change 2.78% 10.38%
SHAREHOLDERS EQUITY
Retained Earnings $47.12M $47.04M
YoY Change 0.16% -201.18%
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$3.516M -$3.440M
YoY Change
Total Liabilities & Shareholders Equity $51.80K $31.09K
YoY Change 66.62% -89.92%

Cashflow Statement

Concept 2024 Q4 2024 Q3 2023 Q3
OPERATING ACTIVITIES
Net Income -$146.2K -$90.72K
YoY Change 61.18% -540.82%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities -$10.00K
YoY Change -91.07%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities $0.00
YoY Change
Cash From Investing Activities $0.00
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 0.000
YoY Change -100.0%
NET CHANGE
Cash From Operating Activities -10.00K
Cash From Investing Activities 0.000
Cash From Financing Activities 0.000
Net Change In Cash -10.00K
YoY Change -147.55%
FREE CASH FLOW
Cash From Operating Activities -$10.00K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
us-gaap Revenues
Revenues
usd
us-gaap Revenues
Revenues
usd
us-gaap Revenues
Revenues
usd
CY2023Q3 us-gaap Revenues
Revenues
usd
CY2023Q3 us-gaap Cost Of Revenue
CostOfRevenue
usd
CY2023Q3 us-gaap Gross Profit
GrossProfit
usd
us-gaap Cost Of Revenue
CostOfRevenue
usd
CY2024Q3 us-gaap Revenues
Revenues
usd
CY2024Q3 us-gaap Cost Of Revenue
CostOfRevenue
usd
us-gaap Revenues
Revenues
usd
CY2024Q3 us-gaap Revenues
Revenues
usd
CY2023Q3 us-gaap Revenues
Revenues
usd
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
dei Entity Central Index Key
EntityCentralIndexKey
0000001961
us-gaap Cost Of Revenue
CostOfRevenue
usd
dei Document Type
DocumentType
10-Q
dei Document Period End Date
DocumentPeriodEndDate
2024-09-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
000-24115
dei Entity Registrant Name
EntityRegistrantName
WORLDS INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
22-1848316
dei Entity Address Address Line1
EntityAddressAddressLine1
11 Royal Road
dei Entity Address State Or Province
EntityAddressStateOrProvince
MA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
02445
dei City Area Code
CityAreaCode
617
dei Local Phone Number
LocalPhoneNumber
725-8900
us-gaap Interest Expense
InterestExpense
56784 usd
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2024Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
57112506 shares
CY2024Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
31253 usd
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
244856 usd
CY2024Q3 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
20545 usd
CY2023Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
20545 usd
CY2024Q3 us-gaap Assets Current
AssetsCurrent
51798 usd
CY2023Q4 us-gaap Assets Current
AssetsCurrent
265401 usd
CY2024Q3 us-gaap Assets
Assets
51798 usd
CY2023Q4 us-gaap Assets
Assets
265401 usd
CY2024Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
798908 usd
CY2023Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
798108 usd
CY2024Q3 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
248765 usd
CY2024Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1746977 usd
CY2023Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1688026 usd
CY2024Q3 us-gaap Notes And Loans Payable
NotesAndLoansPayable
773279 usd
CY2023Q4 us-gaap Notes And Loans Payable
NotesAndLoansPayable
773279 usd
CY2024Q3 us-gaap Liabilities Current
LiabilitiesCurrent
3567929 usd
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
3407564 usd
CY2024Q3 us-gaap Liabilities
Liabilities
3567929 usd
CY2024Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2024Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
250000000 shares
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
250000000 shares
CY2024Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
57112506 shares
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
57112506 shares
CY2024Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
57112506 shares
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
57112506 shares
CY2024Q3 us-gaap Common Stock Value Outstanding
CommonStockValueOutstanding
57113 usd
CY2023Q4 us-gaap Common Stock Value Outstanding
CommonStockValueOutstanding
57113 usd
CY2024Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
42335725 usd
CY2023Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
42335725 usd
CY2024Q3 us-gaap Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
1206913 usd
CY2023Q4 us-gaap Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
1206913 usd
CY2024Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
47115882 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
46741914 usd
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
-3516131 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-3142163 usd
CY2024Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
51798 usd
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
265401 usd
dei Amendment Flag
AmendmentFlag
false
us-gaap Gross Profit
GrossProfit
usd
us-gaap Gross Profit
GrossProfit
usd
CY2023Q4 us-gaap Liabilities
Liabilities
3407564 usd
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
122758 usd
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
72665 usd
CY2024Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
61971 usd
CY2023Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
16263 usd
us-gaap Salaries Wages And Officers Compensation
SalariesWagesAndOfficersCompensation
194426 usd
us-gaap Salaries Wages And Officers Compensation
SalariesWagesAndOfficersCompensation
161760 usd
CY2024Q3 us-gaap Salaries Wages And Officers Compensation
SalariesWagesAndOfficersCompensation
65128 usd
CY2023Q3 us-gaap Salaries Wages And Officers Compensation
SalariesWagesAndOfficersCompensation
53826 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-317184 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-234425 usd
CY2024Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-127099 usd
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-70089 usd
us-gaap Marketable Securities Gain Loss
MarketableSecuritiesGainLoss
76839 usd
CY2023Q3 us-gaap Marketable Securities Gain Loss
MarketableSecuritiesGainLoss
0 usd
us-gaap Interest Expense
InterestExpense
58262 usd
CY2024Q3 us-gaap Interest Expense
InterestExpense
19127 usd
CY2023Q3 us-gaap Interest Expense
InterestExpense
20632 usd
us-gaap Net Income Loss
NetIncomeLoss
-373968 usd
us-gaap Net Income Loss
NetIncomeLoss
-215848 usd
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
-146226 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-90721 usd
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.0
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
CY2024Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
57112506 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
57112506 shares
CY2024Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
57112506 shares
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
57112506 shares
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-3224342 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-29510 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
-3253852 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-95617 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
-3349469 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-3142163 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-105862 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
-3248025 usd
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
-121880 usd
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
CY2024Q3 us-gaap Gross Profit
GrossProfit
usd
us-gaap Increase Decrease In Marketable Securities Restricted
IncreaseDecreaseInMarketableSecuritiesRestricted
usd
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
usd
us-gaap Proceeds From Payments For Long Term Loans For Related Parties
ProceedsFromPaymentsForLongTermLoansForRelatedParties
usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
usd
us-gaap Interest Paid
InterestPaid
usd
us-gaap Interest Paid
InterestPaid
usd
us-gaap Income Taxes Paid
IncomeTaxesPaid
usd
us-gaap Income Taxes Paid
IncomeTaxesPaid
usd
dei Entity Address City Or Town
EntityAddressCityOrTown
Brookline
CY2023Q4 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
148151 usd
us-gaap Marketable Securities Gain Loss
MarketableSecuritiesGainLoss
0 usd
CY2024Q3 us-gaap Marketable Securities Gain Loss
MarketableSecuritiesGainLoss
0 usd
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-90721 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
-3440190 usd
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
-3369905 usd
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
-146226 usd
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
-3516131 usd
us-gaap Net Income Loss
NetIncomeLoss
-373968 usd
us-gaap Net Income Loss
NetIncomeLoss
-215848 usd
us-gaap Increase Decrease In Marketable Securities Restricted
IncreaseDecreaseInMarketableSecuritiesRestricted
-76839 usd
us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
100614 usd
us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
60331 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
59751 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
151827 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-213603 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-80529 usd
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
76839 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
76839 usd
us-gaap Proceeds From Payments For Long Term Loans For Related Parties
ProceedsFromPaymentsForLongTermLoansForRelatedParties
27000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
27000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-213603 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
23310 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
244856 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
7778 usd
CY2024Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
31253 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
31088 usd
WDDD Working Capital Deficiency Going Concern
WorkingCapitalDeficiencyGoingConcern
3516131 usd
us-gaap Stockholders Equity Period Increase Decrease
StockholdersEquityPeriodIncreaseDecrease
3516131 usd
us-gaap Net Cash Provided By Used In Continuing Operations
NetCashProvidedByUsedInContinuingOperations
213603 usd
CY2024Q3 us-gaap Crypto Asset Number Of Units
CryptoAssetNumberOfUnits
200000 interger
CY2024Q3 us-gaap Crypto Asset Number Of Restricted Units
CryptoAssetNumberOfRestrictedUnits
10000 interger
us-gaap Use Of Estimates
UseOfEstimates
<p id="xdx_844_eus-gaap--UseOfEstimates_zP9RmcFRtv5l" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Use of Estimates</b></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The preparation of financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from these estimates. </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-size: 4pt"> </span> </p>
us-gaap Advertising Expense
AdvertisingExpense
0 usd
us-gaap Advertising Expense
AdvertisingExpense
0 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
0 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
0 usd
CY2024Q3 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
20545 usd
CY2023Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
20545 usd
WDDD Assets Range Useful Lives
AssetsRangeUsefulLives
three to five years
us-gaap Effective Income Tax Rate Reconciliation Tax Settlements
EffectiveIncomeTaxRateReconciliationTaxSettlements
0.50 pure
CY2024Q3 us-gaap Notes Payable Current
NotesPayableCurrent
773279 usd
CY2023Q4 us-gaap Notes Payable Current
NotesPayableCurrent
773279 usd
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
16600000 shares
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
17200000 shares
CY2001Q2 us-gaap Litigation Reserve Noncurrent
LitigationReserveNoncurrent
205000 usd
CY2023Q4 us-gaap Litigation Reserve
LitigationReserve
205000 usd
us-gaap Derivatives Embedded Derivatives
DerivativesEmbeddedDerivatives
<p id="xdx_843_eus-gaap--DerivativesEmbeddedDerivatives_z78VkB6YHUyh" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Embedded Conversion Features </b></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company evaluates embedded conversion features within convertible debt under ASC 815 “Derivatives and Hedging” to determine whether the embedded conversion feature(s) should be bifurcated from the host instrument and accounted for as a derivative at fair value with changes in fair value recorded in earnings. If the conversion feature does not require derivative treatment under ASC 815, the instrument is evaluated under ASC 470-20 “Debt with Conversion and Other Options” for consideration of any beneficial conversion feature.</p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
CY2024Q3 us-gaap Convertible Notes Payable
ConvertibleNotesPayable
124230 usd
CY2024Q3 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
649049 usd
CY2024Q3 us-gaap Notes Payable Current
NotesPayableCurrent
773279 usd
CY2024Q3 us-gaap Long Term Debt And Capital Lease Obligations Repayments Of Principal In Next Twelve Months
LongTermDebtAndCapitalLeaseObligationsRepaymentsOfPrincipalInNextTwelveMonths
773279 usd
CY2024Q3 us-gaap Long Term Debt And Capital Lease Obligations Maturities Repayments Of Principal In Year Two
LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearTwo
-0 usd
CY2024Q3 us-gaap Long Term Debt And Capital Lease Obligations Maturities Repayments Of Principal In Year Three
LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearThree
-0 usd
CY2024Q3 us-gaap Long Term Debt And Capital Lease Obligations Maturities Repayments Of Principal In Year Four
LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearFour
-0 usd
CY2024Q3 us-gaap Long Term Debt And Capital Lease Obligations Maturities Repayments Of Principal In Year Five
LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearFive
-0 usd
us-gaap Interest Expense
InterestExpense
56784 usd
CY2024Q3 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
16600000 shares
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
16600000 shares
CY2019Q3 WDDD Terms Of Employment Agreement
TermsOfEmploymentAgreement
5
CY2019Q3 WDDD Terms Of Employment Agreement Renewal Option
TermsOfEmploymentAgreementRenewalOption
1
WDDD Employee Extension
EmployeeExtension
one year extension
WDDD Employee Extension
EmployeeExtension
one year extension
CY2019Q3 WDDD Officer Base Salary
OfficerBaseSalary
200000 usd
CY2019Q3 us-gaap Defined Benefit Plan Assumptions Used Calculating Benefit Obligation Rate Of Compensation Increase
DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease
0.10 pure
CY2019Q3 WDDD Car Allowance
CarAllowance
500 usd
CY2019Q3 WDDD Annua Bonus
AnnuaBonus
0.025 pure
CY2019Q3 WDDD Additional Bonus
AdditionalBonus
75000 usd
CY2019Q3 WDDD Pretax Income Range Lower
PretaxIncomeRangeLower
1.50 pure
CY2019Q3 WDDD Pretax Income Range Higher
PretaxIncomeRangeHigher
2 pure
CY2019Q3 WDDD Additional Bonus Exceed
AdditionalBonusExceed
0.05 pure
CY2019Q3 us-gaap Life Settlement Contracts Investment Method Five Year Disclosure Premiums To Be Paid
LifeSettlementContractsInvestmentMethodFiveYearDisclosurePremiumsToBePaid
10000 usd
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Maximum Number Of Shares Per Employee
ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee
5000000 shares
CY2019Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice
0.25
CY2019Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber
2000000 shares
CY2020Q3 WDDD Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number1
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber1
1500000 shares
CY2021Q3 WDDD Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number1
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber1
1500000 shares
CY2019Q3 us-gaap Life Settlement Contracts Fair Value Method Face Value
LifeSettlementContractsFairValueMethodFaceValue
2000000 usd
CY2019Q3 WDDD Payment Amount Based
PaymentAmountBased
2.99 pure
CY2019Q3 WDDD Restrictive Convenants Amount
RestrictiveConvenantsAmount
12 interger
us-gaap Origination Of Notes Receivable From Related Parties
OriginationOfNotesReceivableFromRelatedParties
47000 usd
CY2023Q2 us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
20000 usd
CY2024Q3 us-gaap Loans Payable
LoansPayable
0 usd
CY2024Q3 us-gaap Accrued Salaries Current
AccruedSalariesCurrent
167577 usd
CY2023Q4 us-gaap Increase Decrease In Accrued Salaries
IncreaseDecreaseInAccruedSalaries
75614 usd
CY2024Q3 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
81188 usd
us-gaap Increase Decrease In Due To Related Parties Current
IncreaseDecreaseInDueToRelatedPartiesCurrent
25000 usd
CY2024Q3 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
248765 usd
CY2023Q4 us-gaap Accrued Salaries Current
AccruedSalariesCurrent
91963 usd
CY2023Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
56188 usd
CY2023Q4 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
148151 usd
CY2024Q3 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
248765 usd
CY2001Q2 us-gaap Litigation Reserve Noncurrent
LitigationReserveNoncurrent
205000 usd
CY2024Q3 us-gaap Loss Contingency Accrual At Carrying Value
LossContingencyAccrualAtCarryingValue
1513560 usd
CY2024Q3 us-gaap Other Accrued Liabilities Noncurrent
OtherAccruedLiabilitiesNoncurrent
10637 usd
us-gaap Legal Fees
LegalFees
17780 usd
CY2024Q3 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
20545 usd
CY2023Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
20545 usd
CY2011Q1 WDDD Retained Shares
RetainedShares
5936115 shares
WDDD Retained Shares Own Value
RetainedSharesOwnValue
0 usd
us-gaap Marketable Securities Gain Loss
MarketableSecuritiesGainLoss
0 usd
us-gaap Marketable Securities Gain Loss
MarketableSecuritiesGainLoss
76839 usd
us-gaap Sale Of Stock Number Of Shares Issued In Transaction
SaleOfStockNumberOfSharesIssuedInTransaction
200000 shares
CY2023Q3 us-gaap Sale Of Stock Price Per Share
SaleOfStockPricePerShare
0.40
CY2024Q3 WDDD Retained Shares Own
RetainedSharesOwn
350000 shares

Files In Submission

Name View Source Status
0001264931-24-000052-index-headers.html Edgar Link pending
0001264931-24-000052-index.html Edgar Link pending
0001264931-24-000052.txt Edgar Link pending
0001264931-24-000052-xbrl.zip Edgar Link pending
ex31_1.htm Edgar Link pending
ex31_2.htm Edgar Link pending
ex32_1.htm Edgar Link pending
ex32_2.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
wddd-20240930.xsd Edgar Link pending
wdddq32024.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
wddd-20240930_cal.xml Edgar Link unprocessable
wddd-20240930_def.xml Edgar Link unprocessable
wddd-20240930_lab.xml Edgar Link unprocessable
wddd-20240930_pre.xml Edgar Link unprocessable
wdddq32024_htm.xml Edgar Link completed